4.6 Article

A Compact β Model of huntingtin Toxicity

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 10, Pages 8188-8196

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.192013

Keywords

-

Funding

  1. National Institutes of Health [R01NS053679, P01NS16375, 2NS45091, AG027936]
  2. DOE [DE-FG02-04ER25626]
  3. National Institutes of Health-NIGMS
  4. University of California at San Francisco Hillblom Center for the Biology of Aging
  5. Huntington Disease Society of America Coalition for the Cure
  6. CHDI, Inc.

Ask authors/readers for more resources

Huntington disease results from an expanded polyglutamine region in the N terminus of the huntingtin protein. HD pathology is characterized by neuronal degeneration and protein inclusions containing N-terminal fragments of mutant huntingtin. Structural information is minimal, though it is believed that mutant huntingtin polyglutamine adopts beta structure upon conversion to a toxic form. To this end, we designed mammalian cell expression constructs encoding compact beta variants of Htt exon 1 N-terminal fragment and tested their ability to aggregate and induce toxicity in cultured neuronal cells. In parallel, we performed molecular dynamics simulations, which indicate that constructs with expanded polyglutamine beta-strands are stabilized by main-chain hydrogen bonding. Finally, we found a correlation between the reactivity to 3B5H10, an expanded polyglutamine antibody that recognizes a compact beta rich hairpin structure, and the ability to induce cell toxicity. These data are consistent with an important role for a compact beta structure in mutant huntingtin-induced cell toxicity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available